Related Experiment Video

Updated: Jul 16, 2026

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
10:21

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

Published on: June 14, 2016

Role of subcellular remodeling in cardiac dysfunction due to congestive heart failure

Andrea P Babick1, Naranjan S Dhalla

  • 1Institute of Cardiovascular Sciences, St. Boniface General Hospital Research Center and Department of Physiology, Faculty of Medicine, University of Manitoba, Winnipeg, Canada.

Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre
|February 17, 2007
PubMed

Insights

Cardiac remodeling impacts heart function in congestive heart failure (CHF). Subcellular organelle changes, not just overall heart structure, are key drivers of cardiac dysfunction in CHF.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Cell Biology

Background:

  • Cardiac remodeling, changes in heart size and shape, is linked to cardiac dysfunction in congestive heart failure (CHF).
  • However, cardiac remodeling can also be associated with preserved or enhanced heart function in conditions like early cardiac hypertrophy.
  • Cardiac dysfunction in CHF is often related to defects in subcellular organelles (myofibrils, sarcoplasmic reticulum, sarcolemma).

Purpose of the Study:

  • To investigate the role of subcellular remodeling in the development of cardiac dysfunction during congestive heart failure (CHF).
  • To explore the relationship between cardiac remodeling and subcellular organelle function in the context of heart failure.

Main Methods:

  • Review of existing studies on cardiac remodeling and subcellular organelle function in CHF.
  • Analysis of genetic and protein level abnormalities in failing hearts.
  • Examination of the effects of renin-angiotensin system blockade on subcellular changes and cardiac performance.

Main Results:

  • Subcellular abnormalities, at genetic and protein levels, are evident in failing hearts.
  • Alterations in subcellular organelles are observed depending on the stage of CHF.
  • Blockade of the renin-angiotensin system showed partial attenuation of subcellular changes and improved cardiac performance in CHF.

Conclusions:

  • Subcellular remodeling, involving molecular and biochemical changes in organelles, plays a significant role in cardiac dysfunction in CHF.
  • Cardiac remodeling's impact on cardiac dysfunction is heavily influenced by concurrent subcellular remodeling.
  • Understanding subcellular remodeling is crucial for developing effective therapeutic strategies for CHF.

More Related Videos

Permanent Ligation of the Left Anterior Descending Coronary Artery in Mice: A Model of Post-myocardial Infarction Remodelling and Heart Failure09:37

Permanent Ligation of the Left Anterior Descending Coronary Artery in Mice: A Model of Post-myocardial Infarction Remodelling and Heart Failure

Published on: December 2, 2014

Studying Left Ventricular Reverse Remodeling by Aortic Debanding in Rodents07:26

Studying Left Ventricular Reverse Remodeling by Aortic Debanding in Rodents

Published on: July 14, 2021

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...